HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Coty Reports Q2 Declines; Arden, IFF Make R&D Investments; More

This article was originally published in The Rose Sheet

Executive Summary

Elizabeth Arden and International Flavors and Fragrances invest in a beauty device and “next-generation” encapsulation technology for hair and personal wash applications, respectively. More news in brief.

You may also be interested in...



Skin Devices Poised To Tap “Wealth Of Unrealized Potential” – Kline

Pricing products more economically and expanding distribution are challenges for skin-care device marketers, but there is significant opportunity for firms that can reach consumers at the mass retail level, says Kline & Company. The market for home-use aesthetic devices grew globally by 22% in 2012.

Prestige Expands UK Eye Care Range In Response To Consumer Demand

A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.

Who’s Hired? Hikma Recruits New US Generics President

A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019362

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel